Weight Loss Injections in Birmingham: What's Actually Available

The biggest misconception: you need a local Birmingham clinic to get these injections

Many people searching for weight loss injections in Birmingham assume they need to find a clinic nearby, book an in-person appointment, and collect a prescription face to face. That was the norm years ago. It is not how the vast majority of people in the UK now access these medicines.

Mounjaro and Wegovy are prescription-only medicines, which means a qualified prescriber must assess your suitability before any treatment is dispensed. But that assessment can happen entirely online, through a GPhC-registered pharmacy with its own prescribing team. At nume (sorry, at nume) consultations are reviewed the same day by a named GPhC-registered Independent Prescriber, a real clinician reading your answers, not a piece of software making an automated decision. Once approved, treatment is dispatched the same day (for orders received by 12pm Monday to Friday) and arrives free the next working day by tracked DPD delivery, in plain unbranded packaging.

So if you live in Moseley, Harborne, Erdington or anywhere else across the West Midlands, a local clinic is not a prerequisite, and if you are based further afield you can read more about how people access a weight loss injections service in Nottingham through the same online model. What matters is finding a pharmacy you can verify on the GPhC register and that has genuine clinical oversight. That is the standard you should hold any provider to, online or otherwise.

Which injection is which, and who the licences actually cover

There are two licensed options, and they work differently. Mounjaro contains tirzepatide, which activates both the GIP and GLP-1 receptors involved in appetite regulation and blood-sugar control. It is the only dual-receptor agonist licensed for weight management in the UK. Wegovy contains semaglutide, a GLP-1 receptor agonist. Both slow gastric emptying, reduce appetite and help people eat less without the constant mental effort of a traditional diet.

In clinical trials, Mounjaro produced average body-weight reductions of around 20–21% over 72 weeks at the highest dose, as reported in the SURMOUNT-1 trial published in the New England Journal of Medicine. Wegovy's STEP 1 trial reported around 15% average reduction at 2.4mg over 68 weeks. These are population averages from controlled conditions, not guarantees for any individual.

On the eligibility question, the licensed criteria for private prescribing are broadly: adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. A prescriber weighs all of this alongside your health history. The three commonly discussed injection options in the UK (tirzepatide, semaglutide, and liraglutide) have different licences and profiles; the first two are what most people qualifying for private treatment will be assessed for.

One practical note on routine: these pens are refrigerated, so most people keep them in the fridge door alongside everyday items and simply set a weekly reminder, and if you want a fuller overview of how a weight loss injection fits into a treatment plan from the first dose through to maintenance, that page sets out what to expect. The injection itself takes seconds. You do not need a nurse or a clinic for that part.

Side effects and what to watch for

The side-effect profile for both medicines is led by the gut. Nausea is the most commonly reported effect, followed by vomiting, diarrhoea, constipation and indigestion. These tend to be most noticeable in the first few weeks or after a dose increase, and they settle for most people as the body adjusts. Fatigue, headache and injection-site reactions are also reported.

Less common but more serious effects to know about: the MHRA issued a Drug Safety Update in January 2026 flagging acute pancreatitis as a known, infrequent but potentially serious risk with GLP-1 medicines. Severe, persistent abdominal pain that spreads to the back, with or without vomiting, should prompt urgent medical attention. Gallbladder problems are another documented possibility. Suspected side effects from any medicine can be reported directly through the MHRA Yellow Card scheme.

These medicines are not recommended during pregnancy, while breastfeeding, or if you are trying to conceive. They are not licensed for people under 18. Anyone with a history of medullary thyroid carcinoma, MEN2, or certain gastrointestinal conditions should discuss this with a prescriber before starting. A thorough clinical assessment exists precisely to catch these things, which is why the prescription process is not a formality. For a fuller picture of what stopping treatment involves, the page on coming off weight loss injections covers what the evidence says.

NHS access versus private prescribing: the honest position for Birmingham

NHS access to these injections is real but limited and phased. NICE recommended tirzepatide (TA1026) for adults with a BMI of 35 or above plus at least one qualifying condition; the NHS rollout began with the highest-need group and is expanding in stages through 2027. Wegovy is available on the NHS through specialist weight management services under a separate NICE recommendation (TA875), but waiting lists in many areas, including across the West Midlands, are long. From April 2026, some GP practices can prescribe tirzepatide under the new GP contract, though participation varies by practice.

If you meet NHS criteria, pursuing that route is entirely reasonable. If you do not meet the current thresholds, or you would prefer not to wait, private prescribing through a regulated online pharmacy is the legal alternative. It is worth understanding what goes into the cost: what weight loss injections actually cost privately varies by dose and provider, and headline figures do not always include the consultation, prescription, delivery or aftercare. The right question to ask of any provider is what the full price covers, not just the lowest number on the page.

If you are ready to see whether you could be suitable, check your eligibility with our prescribers through a free consultation.